30 Molecular features associated with long survival on tebentafusp in previously untreated metastatic uveal melanoma in a phase 3 trial

• Brendan Curti,
• Koustubh Ranade,
• Laura Collins,
• Marlana Orloff,
• Emma Leach,
• Sarah Stanhope,
• Adel Benlahrech,
• Kevin Kim

Affiliations

Brendan Curti

3Providence Cancer Institute, Franz Clinic, Portland, OR, USA

Koustubh Ranade

Aff2 grid.418152.bMedImmune Gaithersburg MD USA

Laura Collins

1 Internal Medicine, Texas Tech University Health Sciences Center El Paso, Paul L Foster School of Medicine, El Paso, Texas, USA

Marlana Orloff

9Thomas Jefferson University Hospital, Philadelphia, PA, USA

Emma Leach

Immunocore, Abingdon, UK

Sarah Stanhope

Immunocore, Abingdon, UK

Adel Benlahrech

Immunocore, Abingdon, UK

Kevin Kim

4San Francisco Oncology Associates, San Francisco, CA, USA